Case Report
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jan 6, 2021; 9(1): 267-273
Published online Jan 6, 2021. doi: 10.12998/wjcc.v9.i1.267
Immunosuppressant treatment for IgG4-related sclerosing cholangitis: A case report
Jong-Sun Kim, Won Ho Choi, Kyung-Ann Lee, Hyun-Sook Kim
Jong-Sun Kim, Won Ho Choi, Kyung-Ann Lee, Hyun-Sook Kim, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul 04401, South Korea
Author contributions: Kim JS, Kim HS contributed to conceptualization; Choi WH, Lee KA contributed to data curation; Kim JS, Lee KA contributed to writing-original draft; Kim JS, Kim HS contributed to writing review and editing; and all authors have read and approve the final manuscript.
Supported by Soonchunhyang University.
Informed consent statement: We provided informed written consent prior to study enrollment.
Conflict-of-interest statement: This study was supported by Soonchunhyang University. There is no conflict-of-interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hyun-Sook Kim, MD, PhD, Full Professor, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, 59 Daesagwanro Youngsangu, Seoul 04401, South Korea. healthyra@schmc.ac.kr
Received: October 1, 2020
Peer-review started: October 1, 2020
First decision: November 3, 2020
Revised: November 9, 2020
Accepted: November 21, 2020
Article in press: November 21, 2020
Published online: January 6, 2021
Processing time: 92 Days and 4.9 Hours
Core Tip

Core Tip: In this paper, we presented immunoglobulin G4-related sclerosing cholangitis (IgG4-SC) which was diagnosed by ACR/EULAR published new classification criteria and was successfully treated using a glucocorticoid with an immunosuppressant and made approved as imaging follow-up. Prompt diagnosis and appropriate treatment of IgG4-SC are important to induce rapid regression and to prevent irreversible fibrosis and biliary stricture. This case emphasizes the proactive attitude to use immuno-suppressants in treatment with IgG4-SC.